Sandner P, Wolf K, Bergmaier U, Gess B, Kurtz A
Institut für Physiologie, Universität Regensburg, Germany.
Kidney Int. 1997 Feb;51(2):448-53. doi: 10.1038/ki.1997.60.
This study examined the expression of EPO, VEGF and VEGF receptor gene under conditions of reduced oxygen supply in primary cultures of rat hepatocytes, and compared it with the expression of these genes in hypoxic rat livers in vivo. To this end we exposed male Sprague-Dawley rats to hypoxia (10% and 8% O2), carbon monoxide (0.1% CO) or injected cobalt chloride (60 mg/kg CoCl2) subcutaneously. For the in vitro experiments we used primary cultures of rat hepatocytes which were kept at high (20% O2) and low (1% O2) oxygen tensions for three hours. The EPO mRNA was up-regulated by hypoxia in vitro and in vivo about 10-fold. The VEGF mRNA was up-regulated fivefold in the hepatocytes only, whereas the in vivo mRNA levels remained unchanged. The mRNA levels of flt-1 were up-regulated threefold by 8% O2 in livers, dependent on the strength of hypoxia (10% caused no changes in flt-1 gene expression) and on the kind of hypoxic stimulus (8% O2 was as effective as 0.1% CO and more effective than cobalt). The mRNA levels of flk-1/KDR and flt-4 remained unchanged in the liver. In vitro there were no changes in the mRNA levels of flt-1, flt-4 and flk-1/KDR. Consequently, the in vivo regulation of VEGF, which might be modulated by induction of flt-1 receptor gene expression, differs from the in vitro cell culture situation and might be different from the EPO regulation in vivo.
本研究检测了大鼠原代肝细胞在低氧供应条件下促红细胞生成素(EPO)、血管内皮生长因子(VEGF)及其受体基因的表达,并将其与低氧大鼠肝脏中这些基因的表达进行了比较。为此,我们将雄性斯普拉格 - 道利大鼠暴露于低氧(10%和8% O₂)、一氧化碳(0.1% CO)环境或皮下注射氯化钴(60 mg/kg CoCl₂)。在体外实验中,我们使用大鼠原代肝细胞,将其分别置于高氧(20% O₂)和低氧(1% O₂)环境中3小时。EPO mRNA在体外和体内均被低氧上调约10倍。VEGF mRNA仅在肝细胞中上调了5倍,而在体内mRNA水平保持不变。肝脏中flt - 1的mRNA水平在8% O₂时上调了3倍,这取决于低氧的强度(10% O₂对flt - 1基因表达无影响)以及低氧刺激的类型(8% O₂与0.1% CO效果相同,且比氯化钴更有效)。肝脏中flk - 1/KDR和flt - 4的mRNA水平保持不变。在体外,flt - 1、flt - 4和flk - 1/KDR的mRNA水平没有变化。因此,VEGF在体内的调节可能通过flt - 1受体基因表达的诱导来调节,这与体外细胞培养情况不同,并且可能与EPO在体内的调节不同。